Nexus AG has announced a change in voting rights following UBS Group AG's increase in its stake to 5.42%, up from 3.20%. This change, effective December 9, 2024, may significantly impact the company's governance and shareholder dynamics. Nexus AG, based in Donaueschingen, Germany, operates in the healthcare software industry and is traded on multiple German stock exchanges.